Literature DB >> 32371106

Variants in the Niemann-Pick type C gene NPC1 are not associated with Parkinson's disease.

Bouchra Ouled Amar Bencheikh1, Konstantin Senkevich2, Uladzislau Rudakou3, Eric Yu3, Kheireddin Mufti3, Jennifer A Ruskey2, Farnaz Asayesh2, Sandra B Laurent2, Dan Spiegelman4, Stanley Fahn5, Cheryl Waters5, Oury Monchi6, Yves Dauvilliers7, Alberto J Espay8, Nicolas Dupré9, Lior Greenbaum10, Sharon Hassin-Baer11, Guy A Rouleau12, Roy N Alcalay13, Edward A Fon2, Ziv Gan-Or14.   

Abstract

Biallelic variants in NPC1, a gene coding for a lysosomal transmembrane protein involved in cholesterol trafficking, may cause Niemann-Pick disease type C (NPC). A few cases of NPC1 variant carriers with Parkinson's disease (PD) have been reported. In addition, pathologic studies have demonstrated phosphorylated alpha-synuclein and Lewy pathology in brains of NPC patients. Therefore, we aimed to examine whether NPC1 genetic variants may be associated with PD. Full sequencing of NPC1 was performed in 2657 PD patients and 3647 controls from 3 cohorts, using targeted sequencing with molecular inversion probes. A total of 9 common variants and 126 rare variants were identified across the 3 cohorts. To examine their association with PD, regression models adjusted for age, sex, and origin were performed for common variants, and optimal sequence Kernel association test (SKAT-O) was performed for rare variants. After correction for multiple comparisons, common and rare NPC1 variants were not associated with PD. Our results do not support a link between heterozygous variants in NPC1 and PD.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lysosomal genes; NPC1; Niemann–Pick disease type C; Parkinson's disease

Mesh:

Substances:

Year:  2020        PMID: 32371106      PMCID: PMC7302975          DOI: 10.1016/j.neurobiolaging.2020.03.021

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  14 in total

1.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Authors:  E Sidransky; M A Nalls; J O Aasly; J Aharon-Peretz; G Annesi; E R Barbosa; A Bar-Shira; D Berg; J Bras; A Brice; C-M Chen; L N Clark; C Condroyer; E V De Marco; A Dürr; M J Eblan; S Fahn; M J Farrer; H-C Fung; Z Gan-Or; T Gasser; R Gershoni-Baruch; N Giladi; A Griffith; T Gurevich; C Januario; P Kropp; A E Lang; G-J Lee-Chen; S Lesage; K Marder; I F Mata; A Mirelman; J Mitsui; I Mizuta; G Nicoletti; C Oliveira; R Ottman; A Orr-Urtreger; L V Pereira; A Quattrone; E Rogaeva; A Rolfs; H Rosenbaum; R Rozenberg; A Samii; T Samaddar; C Schulte; M Sharma; A Singleton; M Spitz; E-K Tan; N Tayebi; T Toda; A R Troiano; S Tsuji; M Wittstock; T G Wolfsberg; Y-R Wu; C P Zabetian; Y Zhao; S G Ziegler
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

Review 2.  Do heterozygous mutations of Niemann-Pick type C predispose to late-onset neurodegeneration: a review of the literature.

Authors:  Susanne A Schneider; Sabina Tahirovic; John Hardy; Michael Strupp; Tatiana Bremova-Ertl
Journal:  J Neurol       Date:  2019-11-07       Impact factor: 4.849

3.  Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.

Authors:  Laurie A Robak; Iris E Jansen; Jeroen van Rooij; André G Uitterlinden; Robert Kraaij; Joseph Jankovic; Peter Heutink; Joshua M Shulman
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

4.  Role of Niemann-Pick type C1 protein in intracellular trafficking of low density lipoprotein-derived cholesterol.

Authors:  J C Cruz; S Sugii; C Yu; T Y Chang
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

5.  SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease.

Authors:  Roy N Alcalay; Victoria Mallett; Benoît Vanderperre; Omid Tavassoly; Yves Dauvilliers; Richard Y J Wu; Jennifer A Ruskey; Claire S Leblond; Amirthagowri Ambalavanan; Sandra B Laurent; Dan Spiegelman; Alexandre Dionne-Laporte; Christopher Liong; Oren A Levy; Stanley Fahn; Cheryl Waters; Sheng-Han Kuo; Wendy K Chung; Blair Ford; Karen S Marder; Un Jung Kang; Sharon Hassin-Baer; Lior Greenbaum; Jean-Francois Trempe; Pavlina Wolf; Petra Oliva; Xiaokui Kate Zhang; Lorraine N Clark; Melanie Langlois; Patrick A Dion; Edward A Fon; Nicolas Dupre; Guy A Rouleau; Ziv Gan-Or
Journal:  Mov Disord       Date:  2019-02-20       Impact factor: 10.338

6.  The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease.

Authors:  Ziv Gan-Or; Laurie J Ozelius; Anat Bar-Shira; Rachel Saunders-Pullman; Anat Mirelman; Ruth Kornreich; Mali Gana-Weisz; Deborah Raymond; Liron Rozenkrantz; Andres Deik; Tanya Gurevich; Susan J Gross; Nicole Schreiber-Agus; Nir Giladi; Susan B Bressman; Avi Orr-Urtreger
Journal:  Neurology       Date:  2013-03-27       Impact factor: 9.910

7.  Niemann-Pick disease type C1 predominantly involving the frontotemporal region, with cortical and brainstem Lewy bodies: an autopsy case.

Authors:  Yoichi Chiba; Hiraku Komori; Shiro Takei; Sanae Hasegawa-Ishii; Noriko Kawamura; Kaori Adachi; Eiji Nanba; Masanori Hosokawa; Yasushi Enokido; Zen Kouchi; Futoshi Yoshida; Atsuyoshi Shimada
Journal:  Neuropathology       Date:  2013-05-27       Impact factor: 1.906

8.  Parkinsonism syndrome in heterozygotes for Niemann-Pick C1.

Authors:  Hans H Kluenemann; John G Nutt; Marie Y Davis; Thomas D Bird
Journal:  J Neurol Sci       Date:  2013-09-03       Impact factor: 3.181

9.  Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.

Authors:  Mike A Nalls; Cornelis Blauwendraat; Costanza L Vallerga; Karl Heilbron; Sara Bandres-Ciga; Diana Chang; Manuela Tan; Demis A Kia; Alastair J Noyce; Angli Xue; Jose Bras; Emily Young; Rainer von Coelln; Javier Simón-Sánchez; Claudia Schulte; Manu Sharma; Lynne Krohn; Lasse Pihlstrøm; Ari Siitonen; Hirotaka Iwaki; Hampton Leonard; Faraz Faghri; J Raphael Gibbs; Dena G Hernandez; Sonja W Scholz; Juan A Botia; Maria Martinez; Jean-Christophe Corvol; Suzanne Lesage; Joseph Jankovic; Lisa M Shulman; Margaret Sutherland; Pentti Tienari; Kari Majamaa; Mathias Toft; Ole A Andreassen; Tushar Bangale; Alexis Brice; Jian Yang; Ziv Gan-Or; Thomas Gasser; Peter Heutink; Joshua M Shulman; Nicholas W Wood; David A Hinds; John A Hardy; Huw R Morris; Jacob Gratten; Peter M Visscher; Robert R Graham; Andrew B Singleton
Journal:  Lancet Neurol       Date:  2019-12       Impact factor: 44.182

10.  Alpha galactosidase A activity in Parkinson's disease.

Authors:  R N Alcalay; P Wolf; O A Levy; U J Kang; C Waters; S Fahn; B Ford; S H Kuo; N Vanegas; H Shah; C Liong; S Narayan; M W Pauciulo; W C Nichols; Z Gan-Or; G A Rouleau; W K Chung; P Oliva; J Keutzer; K Marder; X K Zhang
Journal:  Neurobiol Dis       Date:  2018-02-02       Impact factor: 5.996

View more
  5 in total

Review 1.  A Practical Approach to Early-Onset Parkinsonism.

Authors:  Giulietta M Riboldi; Emanuele Frattini; Edoardo Monfrini; Steven J Frucht; Alessio Di Fonzo
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

Review 2.  Glycosphingolipid metabolism and its role in ageing and Parkinson's disease.

Authors:  Kerri-Lee Wallom; María E Fernández-Suárez; David A Priestman; Danielle Te Vruchte; Mylene Huebecker; Penelope J Hallett; Ole Isacson; Frances M Platt
Journal:  Glycoconj J       Date:  2021-11-10       Impact factor: 2.916

Review 3.  Neurodegenerative Disease Risk in Carriers of Autosomal Recessive Disease.

Authors:  Sophia R L Vieira; Huw R Morris
Journal:  Front Neurol       Date:  2021-06-04       Impact factor: 4.003

Review 4.  Insights into Lewy body disease from rare neurometabolic disorders.

Authors:  Daniel Erskine; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2021-05-30       Impact factor: 3.575

Review 5.  The Multiple Roles of Sphingomyelin in Parkinson's Disease.

Authors:  Paola Signorelli; Carmela Conte; Elisabetta Albi
Journal:  Biomolecules       Date:  2021-09-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.